Breast Tumor Ablation Study Parameters To Be Reviewed By FDA Panel
This article was originally published in The Gray Sheet
Executive Summary
Clinical trial criteria for studying percutaneous breast tumor removal devices will be explored by FDA's General & Plastic Surgery Devices Panel during a July 24 meeting in Gaithersburg, Md